Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA1, p42 and p38α
- 24 April 2007
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1771 (7) , 883-892
- https://doi.org/10.1016/j.bbalip.2007.04.010
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Of Spiders and Crabs: The Emergence of Lysophospholipids and Their Metabolic Pathways as Targets for Therapy in CancerClinical Cancer Research, 2006
- Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligandsBioorganic & Medicinal Chemistry Letters, 2006
- Lysophosphatidic acid stimulates PC‐3 prostate cancer cell matrigel invasion through activation of RhoA and NF‐κB activityMolecular Carcinogenesis, 2006
- Dipeptidyl Peptidase Inhibits Malignant Phenotype of Prostate Cancer Cells by Blocking Basic Fibroblast Growth Factor Signaling PathwayCancer Research, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Dynamic process of prostate cancer metastasis to boneJournal of Cellular Biochemistry, 2003
- The emerging role of lysophosphatidic acid in cancerNature Reviews Cancer, 2003
- Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg FamilyJournal of Biological Chemistry, 2003
- Role for 18:1 Lysophosphatidic Acid as an Autocrine Mediator in Prostate Cancer CellsJournal of Biological Chemistry, 2002
- Bioactive Lysophospholipids and Their G Protein-Coupled ReceptorsExperimental Cell Research, 1999